2 Exhibit 1: US market penetration vs projected market size In the most recent wave of developments, Novo secured an FDA label expansion for Wegovy for cardiovascular risk reduction (a key step toward medicalizing reimbursement beyond cosmetic weight loss) and, importantly for premiumization, also announced approval of a once-daily oral Wegovy option potentially widening adoption among injectionaverse patients while intensifying competition in convenience-led segments
We have developed a deep understanding of healthcare systems in many major geographies, having advised both public and private players in the space
doi: 10.1016/j.cmet.2019.09.016 Summary Keywords type 2 diabetes mellitus, cardiovascular disease, acylcarnitine, metabolism, relationship Citation Zhao S, Liu M-L, Huang B, Zhao F-R, Li Y, Cui X-T and Lin R (2021) Acetylcarnitine Is Associated With Cardiovascular Disease Risk in Type 2 Diabetes Mellitus
However, if your baby has a vitamin B12 deficiency, they may also need treatment